期刊文献+

原发性胃恶性淋巴瘤的临床诊治分析

Clinical Analysis of Primary Gastric Malignant Lymphoma
在线阅读 下载PDF
导出
摘要 目的 探讨原发性胃恶性淋巴瘤(PGML)的诊断、治疗与预后.方法 回顾分析2000年~2008年收治的29例经术后病理确诊为原发性胃恶性淋巴瘤的临床资料.结果 29例患者中仅6例术前经胃镜活检确诊,所有患者均行手术治疗,26 例患者术后辅以化疗,手术切除率为89.7%.免疫组化证实B细胞型淋巴瘤27例,T细胞型淋巴瘤2例.25例获得随访,5年生存率为56%,其中Ⅰ期+Ⅱ期5年生存率为61.9%(13/21);Ⅲ+Ⅳ期5年生存率为25 %(1/4).结论 PGML临床表现无特异性,容易漏诊.胃镜活检是术前诊断该病的主要方法,手术切除联合应用化疗是治疗PGML的重要手段.免疫组化及临床分期对PGML的分类以及判断预后有重要意义. Objective To explore the diagnosis,treatment and prognosis of primary gastric malignant lymphoma ( PGML).Methods 29 cases of PGML were retrospectively analyzed in our hospital from 2000 to 2008.Results Among the 29 cases,only 6 were definitely diagnosed by gastroscopy before operation.All patients underwent operative treatment and most of the patients received chemotherapy,the resectable rate of PGML was 89.7%.27 cases exhibited B-cell phenotype and 2 patients exhibited T-cell phenotype by immunohistochemistry examination. Follow-up was complete in 25 patients,the 5-year survival rate was 56%,the 5-year survival rates of stages of I and Ⅱ patients were 61.9%,and stages of Ⅲ and lg were 25%.Conclusions The clinical manifestations of PGML have no specificity, and PGML is very likely to be misdiagnosed or neglected.Gastroscope biopsy is the main approach of diagnosis before operation,surgical resection and adjuvant chemotherapy play important role in treatment of PGML.Immunohistochemistry examination and clinical term have significance in judgement of prognosis and classification.
出处 《中国血液流变学杂志》 CAS 2010年第2期264-266,共3页 Chinese Journal of Hemorheology
关键词 胃肿瘤 淋巴瘤 预后 诊断 治疗 Stomach neoplasms Lymphoma Prognosis Diagnosis Treatment
作者简介 郑丁铖(1984-),男,浙江江山人,在读硕士研究生,主要从事消化道肿瘤的基础和临床研究. 通讯作者
  • 相关文献

参考文献8

二级参考文献60

  • 1何义富,李宇红,黄慧强,夏忠军,孙晓非,林桐榆,林旭滨,袁中玉,李志铭,王风华,王树森,姜文奇.59例原发性胃非霍奇金淋巴瘤的临床分析[J].癌症,2005,24(4):475-477. 被引量:11
  • 2陈晓琴,万里,陆其明.原发性胃淋巴瘤的临床和内镜下表现[J].中国内镜杂志,2005,11(8):877-878. 被引量:9
  • 3蔡阳,朱玮,封光华,叶静,方欣.原发性胃恶性淋巴瘤的诊断与治疗[J].中国普通外科杂志,2005,14(10):728-729. 被引量:3
  • 4Koch P, d′Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin's lymphoma: Anatomic and histological distribution, clinical features and survival data of 371 patients registered in the German muticenter study GIT NHL01/92. J Clin Oncol, 2001,19 : 3861-3873.
  • 5Dawson IM, Comes JS, Morson BC. Primary malignant lymphoid tumors of the intestinal tract, report of 37 cases with a study of factorsinfluencing prognosis. Br J Surg, 1961,49 : 80-89.
  • 6Carbone PP, Kaplan HS, Lukes R J, et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res, 1971,31 : 1860.
  • 7Shipp M, Harrington D, Anderson J, et al. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non- Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med, 1993,329 : 987-994.
  • 8National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer, 1982,49: 2112-2135.
  • 9Fischbach W, Dragasics B, Kolve Goebeler ME, et al. Primary gastric B-cell lymphoma: results of a prospective muhicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology, 2000, 119 : 1191-1202.
  • 10Maor MH, Velasquez WS, Fuller LM, et al. Stomach conservation in stages Ⅰ E and Ⅱ E gastric non-Hodgkin's lymphoma. J Clin Oncol, 1990,8:266-271.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部